Back
FTI Consulting Vs. ANI Pharmaceuticals Industry Stock Comparison
Sell
50
FCN
FTI Consulting
Last Price:
203.95
Seasonality Move:
2.31%
Buy
59
ANIP
ANI Pharmaceuticals
Last Price:
61.42
Seasonality Move:
5.08%
Sell
50
FTI Consulting (FCN)
is a Sell
Is FTI Consulting a Buy, Sell or Hold?
- The current FTI Consulting [FCN] share price is $204.27. The Score for FCN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- FCN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.67. The Score for ANIP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FCN Stock Price Chart
What is FTI Consulting's stock price today?
-
The FTI Consulting share price today is $204.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCN is experiencing selling pressure, which indicates risk of future bearish movement.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
FCN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.04 | Sell |
| Relative Strength Index (14 RSI): | 40.49 | Sell |
| Chaikin Money Flow: | -138565 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (200.47 - 226.61) | Sell |
| Bollinger Bands (100): | (210.7 - 228.1) | Sell |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 60.46 | Buy |
| Chaikin Money Flow: | 225492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.73 - 59.67) | Buy |
| Bollinger Bands (100): | (57.7 - 62.92) | Buy |
FCN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 200.38 | Buy |
| 20-day SMA: | 211.11 | Sell |
| 50-day SMA: | 218.82 | Sell |
| 200-day SMA: | 214.02 | Sell |
| 8-day EMA: | 202.82 | Buy |
| 20-day EMA: | 208.39 | Sell |
| 50-day EMA: | 215.21 | Sell |
| 200-day EMA: | 213.6 | Sell |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.22 | Buy |
| 20-day SMA: | 58.64 | Buy |
| 50-day SMA: | 58.71 | Buy |
| 200-day SMA: | 62.04 | Sell |
| 8-day EMA: | 58.8 | Buy |
| 20-day EMA: | 58.52 | Buy |
| 50-day EMA: | 58.98 | Buy |
| 200-day EMA: | 59.88 | Buy |
FTI Consulting Earnings Growth & FCN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $0.59 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.82 per share.
FTI Consulting Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||